Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure

Shigeki Sasaki, Tomohiro Hashimoto, Norihiro Obana, Hideyo Yasuda, Yoshimasa Uehara, Minoru Maeda

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.

Original languageEnglish
Pages (from-to)1019-1022
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume8
Issue number9
DOIs
Publication statusPublished - May 1 1998

Fingerprint

CDC2 Protein Kinase
Protein Kinases
Phosphotransferases
triethylene glycol
maleimide

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure. / Sasaki, Shigeki; Hashimoto, Tomohiro; Obana, Norihiro; Yasuda, Hideyo; Uehara, Yoshimasa; Maeda, Minoru.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 8, No. 9, 01.05.1998, p. 1019-1022.

Research output: Contribution to journalArticle

Sasaki, Shigeki ; Hashimoto, Tomohiro ; Obana, Norihiro ; Yasuda, Hideyo ; Uehara, Yoshimasa ; Maeda, Minoru. / Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure. In: Bioorganic and Medicinal Chemistry Letters. 1998 ; Vol. 8, No. 9. pp. 1019-1022.
@article{4892604db50a437da26e1e90b39133c8,
title = "Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure",
abstract = "New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.",
author = "Shigeki Sasaki and Tomohiro Hashimoto and Norihiro Obana and Hideyo Yasuda and Yoshimasa Uehara and Minoru Maeda",
year = "1998",
month = "5",
day = "1",
doi = "10.1016/S0960-894X(98)00163-2",
language = "English",
volume = "8",
pages = "1019--1022",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure

AU - Sasaki, Shigeki

AU - Hashimoto, Tomohiro

AU - Obana, Norihiro

AU - Yasuda, Hideyo

AU - Uehara, Yoshimasa

AU - Maeda, Minoru

PY - 1998/5/1

Y1 - 1998/5/1

N2 - New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.

AB - New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.

UR - http://www.scopus.com/inward/record.url?scp=0032080613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032080613&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(98)00163-2

DO - 10.1016/S0960-894X(98)00163-2

M3 - Article

C2 - 9871700

AN - SCOPUS:0032080613

VL - 8

SP - 1019

EP - 1022

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 9

ER -